Find clinical trials for Lymphoma in Valencia, VC

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

B-Cell Lymphoma

Leukemia

Non-Hodgkin Lymphoma

Lymphoid Leukemia

Diffuse Large B-Cell Lymphoma

Precursor Cell Lymphoblastic Leukemia-Lymphoma

B-Cell Chronic Lymphocytic Leukemia

Lymphoma trials near Valencia, VC, ESP:

A Trial to Learn if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Participants With Follicular Lymphoma and Marginal Zone Lymphoma (OLYMPIA-5)

focused on patients who have one of two types of cancer: follicular lymphoma (FL) or marginal zone lymphoma (MZL) that has come bac...

Enrolling

Marginal Zone Lymphoma (MZL)

Relapsed/Refractory Follicular Lymphoma

Drug: Rituximab

Drug: Lenalidomide

Phase 3

Regeneron Pharmaceuticals

Valencia, Spain and 60 other locations

A Study to Evaluate the Safety and Anti-cancer Activity of Loncastuximab Tesirine in Combination With Other Anti-cancer Agents in Participants With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (LOTIS-7)

The primary objective of this study is to characterize the safety and tolerability of loncastuximab tesirine in combination with polatuzumab vedotin,...

Enrolling

Refractory B-Cell Non-Hodgkin Lymphoma

Relapsed B-Cell Non-Hodgkin Lymphoma

Drug: Mosunetuzumab

Drug: Obinutuzumab

Phase 1

ADC Therapeutics

Valencia, Spain and 26 other locations

A Study of CPI-0209 in Patients With Advanced Solid Tumors and Lymphomas

First-in-human, open-label, sequential dose escalation and expansion study of CPI-0209 in patients with advanced solid tumors and lymphomas....

Enrolling

Lymphoma, T-Cell

Diffuse Large B Cell Lymphoma

Drug: CPI-0209

Phase 1, Phase 2

Constellation Pharmaceuticals

Valencia, Spain and 50 other locations

Study of Lacutamab in Peripheral T-cell Lymphoma

with Refractory/Relapsing (R/R) KIR3DL2 positive Peripheral T Cell Lymphoma (PTCL) : Not Other Specified (NOS), PTCL-TFH (including Angioimm...

Enrolling

Peripheral T Cell Lymphoma

Relapse/Recurrence

Drug: Lacutamab

Drug: Oxaliplatine

Phase 2

The Lymphoma Academic Research Organisation

Valencia, Spain and 63 other locations

A Phase 3 Open Label Randomized Study to Compare the Efficacy and Safety of Rituximab Plus Lenalidomide (CC-5013) Versus Rituximab Plus Chemotherapy Followed by Rituximab in Subjects With Previously Untreated Follicular Lymphoma (RELEVANCE)

The purpose of this study is to find out if lenalidomide when given along with rituximab can help to control the disease and also increase the length...

Active, not recruiting

Follicular Lymphoma

Drug: Rituximab - CHOP

Drug: Lenalidomide

Phase 3

The Lymphoma Academic Research Organisation

Valencia, Spain and 34 other locations

A Frontline Therapy Trial in Participants With Advanced Classical Hodgkin Lymphoma

treatment of advanced classical Hodgkin lymphoma(HL)...

Active, not recruiting

Hodgkin Lymphoma

Drug: brentuximab vedotin

Drug: bleomycin

Phase 3

Takeda

Valencia, Spain and 215 other locations

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of Relatlimab Plus Nivolumab in Pediatric and Young Adults With Hodgkin and Non-Hodgkin Lymphoma (RELATIVITY-069)

and preliminary efficacy of relatlimab plus nivolumab in pediatric and young adult participants with recurrent or refractory classical Hodgkin lymphoma...

Enrolling

Lymphoma, Non-Hodgkin

Hodgkin Disease

Drug: Relatlimab

Drug: Nivolumab

Phase 1, Phase 2

Bristol-Myers Squibb (BMS)

Valencia, Spain and 73 other locations

Study to Evaluate Loncastuximab Tesirine With Rituximab Versus Immunochemotherapy in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (LOTIS 5)

The purpose of this study is to evaluate the efficacy of loncastuximab tesirine (ADCT-402) combined with rituximab compared to standard immunochemoth...

Enrolling

Relapsed Diffuse Large B-Cell Lymphoma

Refractory Diffuse Large B-Cell Lymphoma

Drug: Oxaliplatin

Drug: Gemcitabine

Phase 3

ADC Therapeutics

Valencia, Spain and 140 other locations

Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma

This trial will study two treatment combinations for classical Hodgkin lymphoma (cHL). This trial will find out if these two treatment combi...

Active, not recruiting

Hodgkin Lymphoma

Drug: doxorubicin

Drug: brentuximab vedotin

Phase 2

Seagen

Valencia, Other, Spain and 75 other locations

Study of BTK Inhibitor LOXO-305 Versus Approved BTK Inhibitor Drugs in Patients With Mantle Cell Lymphoma (MCL) (BRUIN-MCL-321)

This is a study for participants with a type of blood cancer called mantle cell lymphoma (MCL). The main purpose is to compare pirtobrutinib...

Active, not recruiting

Lymphoma, Mantle-Cell

Drug: Ibrutinib

Drug: Pirtobrutinib

Phase 3

Loxo Oncology

Valencia, Spain and 226 other locations

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms

Find clinical trials for Lymphoma in .css-epvm6{white-space:nowrap;}Valencia, VC

Related conditions:

Lymphoma trials near Valencia, VC, ESP:

A Trial to Learn if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Participants With Follicular Lymphoma and Marginal Zone Lymphoma (OLYMPIA-5)

A Study to Evaluate the Safety and Anti-cancer Activity of Loncastuximab Tesirine in Combination With Other Anti-cancer Agents in Participants With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (LOTIS-7)

A Study of CPI-0209 in Patients With Advanced Solid Tumors and Lymphomas

Study of Lacutamab in Peripheral T-cell Lymphoma

A Phase 3 Open Label Randomized Study to Compare the Efficacy and Safety of Rituximab Plus Lenalidomide (CC-5013) Versus Rituximab Plus Chemotherapy Followed by Rituximab in Subjects With Previously Untreated Follicular Lymphoma (RELEVANCE)

A Frontline Therapy Trial in Participants With Advanced Classical Hodgkin Lymphoma

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of Relatlimab Plus Nivolumab in Pediatric and Young Adults With Hodgkin and Non-Hodgkin Lymphoma (RELATIVITY-069)

Study to Evaluate Loncastuximab Tesirine With Rituximab Versus Immunochemotherapy in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (LOTIS 5)

Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma

Study of BTK Inhibitor LOXO-305 Versus Approved BTK Inhibitor Drugs in Patients With Mantle Cell Lymphoma (MCL) (BRUIN-MCL-321)

Find clinical trials for Lymphoma in Valencia, VC